Kopran Past Earnings Performance

Past criteria checks 5/6

Kopran has been growing earnings at an average annual rate of 6.8%, while the Pharmaceuticals industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 10.6% per year. Kopran's return on equity is 10.4%, and it has net margins of 8.3%.

Key information

6.8%

Earnings growth rate

4.5%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate10.6%
Return on equity10.4%
Net Margin8.3%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Kopran makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:524280 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 246,1465105230
31 Dec 235,7894045550
30 Sep 235,7803155360
30 Jun 235,4242245260
31 Mar 235,5102725190
31 Dec 225,4343674860
30 Sep 225,1724984870
30 Jun 225,2786234660
31 Mar 224,7756104490
31 Dec 214,7465864400
30 Sep 214,5485424160
30 Jun 214,4635374090
31 Mar 214,9186163980
31 Dec 204,3935143920
30 Sep 204,2744203890
30 Jun 203,9623103640
31 Mar 203,5952103940
31 Dec 193,7182394100
30 Sep 193,7712844110
30 Jun 193,8152714050
31 Mar 193,5792403970
31 Dec 183,5582153780
30 Sep 183,4472043670
30 Jun 183,2402063630
31 Mar 183,1332053470
31 Dec 173,1132623750
30 Sep 172,9432373630
30 Jun 172,9772373660
31 Mar 173,1881993380
31 Dec 162,9301973130
30 Sep 162,9201303190
30 Jun 162,9501223030
31 Mar 162,9631073040
31 Mar 153,257-3913140
31 Mar 143,0281724560

Quality Earnings: 524280 has high quality earnings.

Growing Profit Margin: 524280's current net profit margins (8.3%) are higher than last year (4.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 524280's earnings have grown by 6.8% per year over the past 5 years.

Accelerating Growth: 524280's earnings growth over the past year (87.1%) exceeds its 5-year average (6.8% per year).

Earnings vs Industry: 524280 earnings growth over the past year (87.1%) exceeded the Pharmaceuticals industry 17%.


Return on Equity

High ROE: 524280's Return on Equity (10.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.